Status:
COMPLETED
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
Lead Sponsor:
Qiaoqiao Li
Collaborating Sponsors:
Chinese Institute of Food Science and Technology
Conditions:
Anastomotic Leak Esophagus
Eligibility:
All Genders
18-75 years
Brief Summary
To investigate the clinical factors and preoperative treatment to the future anastomotic location of cervical esophagus that were correlated with anastomotic leaks in esophageal squamous cell carcinom...
Detailed Description
The goal of this observational study is to investigate the clinical factors and preoperative treatment to the future anastomotic location of cervical esophagus that were correlated with anastomotic le...
Eligibility Criteria
Inclusion
- histologically confirmed ESCC;
- clinically staged as T3-4aN0M0 or T1-4aN+M0 by the eighth edition of the American Joint Committee on Cancer and treated with nCRT followed by McKeown esophagectomy24;
- aged 18-75 years;
- Eastern Cooperative Oncology Group performance status score ≤ 2.
Exclusion
- cervical esophageal cancer;
- previously treated with chest radiotherapy, esophageal, or gastric surgery;
- insufficient clinical data.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT06556355
Start Date
November 1 2022
End Date
September 15 2023
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060